Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Differential PAX3 functions in normal skin melanocytes and melanoma cells.

Medic S, Rizos H, Ziman M.

Biochem Biophys Res Commun. 2011 Aug 12;411(4):832-7. doi: 10.1016/j.bbrc.2011.07.053. Epub 2011 Jul 23.

PMID:
21802410
[PubMed - indexed for MEDLINE]
2.

PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas).

Medic S, Ziman M.

PLoS One. 2010 Apr 22;5(4):e9977. doi: 10.1371/journal.pone.0009977.

PMID:
20421967
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

PAX3 across the spectrum: from melanoblast to melanoma.

Medic S, Ziman M.

Crit Rev Biochem Mol Biol. 2009 Jun;44(2-3):85-97. doi: 10.1080/10409230902755056. Review.

PMID:
19401874
[PubMed - indexed for MEDLINE]
4.

Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro.

Wang Q, Kumar S, Slevin M, Kumar P.

Cancer Res. 2006 Sep 1;66(17):8574-80.

PMID:
16951170
[PubMed - indexed for MEDLINE]
Free Article
5.

Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.

Bosserhoff AK, Ellmann L, Kuphal S.

Exp Dermatol. 2011 May;20(5):435-40. doi: 10.1111/j.1600-0625.2011.01271.x.

PMID:
21496114
[PubMed - indexed for MEDLINE]
6.

Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Kubic JD, Young KP, Plummer RS, Ludvik AE, Lang D.

Pigment Cell Melanoma Res. 2008 Dec;21(6):627-45. doi: 10.1111/j.1755-148X.2008.00514.x. Review.

PMID:
18983540
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.

Berlin I, Denat L, Steunou AL, Puig I, Champeval D, Colombo S, Roberts K, Bonvin E, Bourgeois Y, Davidson I, Delmas V, Nieto L, Goding CR, Larue L.

Mol Cell Biol. 2012 Apr;32(7):1237-47. doi: 10.1128/MCB.06257-11. Epub 2012 Jan 30.

PMID:
22290434
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity.

He SJ, Stevens G, Braithwaite AW, Eccles MR.

Mol Cancer Ther. 2005 Jun;4(6):996-1003.

PMID:
15956257
[PubMed - indexed for MEDLINE]
Free Article
9.

TBX2 expression is regulated by PAX3 in the melanocyte lineage.

Liu F, Cao J, Lv J, Dong L, Pier E, Xu GX, Wang RA, Xu Z, Goding C, Cui R.

Pigment Cell Melanoma Res. 2013 Jan;26(1):67-77. doi: 10.1111/pcmr.12029. Epub 2012 Nov 21.

PMID:
23020925
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Adhesion, migration and communication in melanocytes and melanoma.

Haass NK, Smalley KS, Li L, Herlyn M.

Pigment Cell Res. 2005 Jun;18(3):150-9. Review.

PMID:
15892711
[PubMed - indexed for MEDLINE]
11.

Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.

Vachtenheim J, Novotná H.

Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):1075-82.

PMID:
10644012
[PubMed - indexed for MEDLINE]
12.

A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.

Bonvin E, Falletta P, Shaw H, Delmas V, Goding CR.

Mol Cell Biol. 2012 Nov;32(22):4674-83. doi: 10.1128/MCB.01067-12. Epub 2012 Sep 17.

PMID:
22988297
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

PAX3 expression in primary melanomas and nevi.

Plummer RS, Shea CR, Nelson M, Powell SK, Freeman DM, Dan CP, Lang D.

Mod Pathol. 2008 May;21(5):525-30. doi: 10.1038/modpathol.3801019. Epub 2008 Mar 7.

PMID:
18327212
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

PAX3 Is extensively expressed in benign and malignant tissues of the melanocytic lineage in humans.

He S, Yoon HS, Suh BJ, Eccles MR.

J Invest Dermatol. 2010 May;130(5):1465-8. doi: 10.1038/jid.2009.434. Epub 2010 Jan 28. No abstract available.

PMID:
20107488
[PubMed - indexed for MEDLINE]
Free Article
15.

Pax3 functions at a nodal point in melanocyte stem cell differentiation.

Lang D, Lu MM, Huang L, Engleka KA, Zhang M, Chu EY, Lipner S, Skoultchi A, Millar SE, Epstein JA.

Nature. 2005 Feb 24;433(7028):884-7.

PMID:
15729346
[PubMed - indexed for MEDLINE]
16.

Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.

Spanjaard RA, Whren KM, Graves C, Bhawan J.

Int J Cancer. 2007 Mar 15;120(6):1304-10.

PMID:
17187358
[PubMed - indexed for MEDLINE]
17.

p54nrb is a new regulator of progression of malignant melanoma.

Schiffner S, Zimara N, Schmid R, Bosserhoff AK.

Carcinogenesis. 2011 Aug;32(8):1176-82. doi: 10.1093/carcin/bgr103. Epub 2011 Jun 3.

PMID:
21642354
[PubMed - indexed for MEDLINE]
Free Article
18.

Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter.

Galibert MD, Yavuzer U, Dexter TJ, Goding CR.

J Biol Chem. 1999 Sep 17;274(38):26894-900.

PMID:
10480898
[PubMed - indexed for MEDLINE]
Free Article
19.

PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.

Lee SB, Doberstein K, Baumgarten P, Wieland A, Ungerer C, Bürger C, Hardt K, Boehncke WH, Pfeilschifter J, Mihic-Probst D, Mittelbronn M, Gutwein P.

PLoS One. 2011;6(8):e22312. doi: 10.1371/journal.pone.0022312. Epub 2011 Aug 18.

PMID:
21876729
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pax3 transcripts in melanoblast development.

Blake JA, Ziman MR.

Dev Growth Differ. 2005 Dec;47(9):627-35.

PMID:
16316407
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk